Literature DB >> 18207386

Lifestyle habits as a contributor to anti-cancer treatment failure.

Floris A de Jong1, Alex Sparreboom, Jaap Verweij, Ron H J Mathijssen.   

Abstract

Lifestyle may have serious consequences for cancer treatment outcome, which is a fact that both physicians and patients are often not explicitly aware of, thereby unwillingly exposing the patient to possible danger. In certain cases, patient behaviour can lead to potentially life-threatening adverse events, whilst in other cases the clinical benefit of anti-cancer therapy can be diminished. In this review, we focus on the role of certain habits (like cigarette smoking, alcohol use and the use of complementary and alternative medicine) and discuss the effects they may have on anti-cancer medication. Also patient compliance to prescribed anti-cancer drugs is a factor frequently overlooked if treatment does not follow the expectations, which gains importance with the increasingly frequent prescription of oral anti-cancer agents.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18207386     DOI: 10.1016/j.ejca.2007.12.012

Source DB:  PubMed          Journal:  Eur J Cancer        ISSN: 0959-8049            Impact factor:   9.162


  7 in total

Review 1.  Determining the optimal dose in the development of anticancer agents.

Authors:  Ron H J Mathijssen; Alex Sparreboom; Jaap Verweij
Journal:  Nat Rev Clin Oncol       Date:  2014-03-25       Impact factor: 66.675

2.  Assessing stakeholder opinion on relations between cancer patient groups and pharmaceutical companies in Europe.

Authors:  Susanna Leto di Priolo; Andras Fehervary; Phil Riggins; Kathy Redmond
Journal:  Patient       Date:  2012       Impact factor: 3.883

3.  The Peter Brojde lung cancer centre: a model of integrative practice.

Authors:  M Grossman; J Agulnik; G Batist
Journal:  Curr Oncol       Date:  2012-06       Impact factor: 3.677

4.  Effects of methimazole on the elimination of irinotecan.

Authors:  Jessica M van der Bol; Theo J Visser; Walter J Loos; Floris A de Jong; Erik A C Wiemer; Maarten O van Aken; Andre S Planting; Jan H Schellens; Jaap Verweij; Ron H J Mathijssen
Journal:  Cancer Chemother Pharmacol       Date:  2010-08-01       Impact factor: 3.333

5.  Impact of Open Dialogue about Complementary Alternative Medicine-A Phase II Randomized Controlled Trial.

Authors:  Mette Stie; Charlotte Delmar; Birgitte Nørgaard; Lars Henrik Jensen
Journal:  Cancers (Basel)       Date:  2022-02-14       Impact factor: 6.575

6.  Efficacy of open dialogue about complementary and alternative medicine compared with standard care in improving quality of life in patients undergoing conventional oncology treatment (CAMONCO 2): protocol for a randomised controlled trial.

Authors:  Mette Stie; Charlotte Delmar; Birgitte Nørgaard; Lars Henrik Jensen
Journal:  BMJ Open       Date:  2022-04-25       Impact factor: 3.006

7.  Synthesis and Properties of Magnetic Fe3O4/PCL Porous Biocomposite Scaffolds with Different Sizes and Quantities of Fe3O4 Particles.

Authors:  Jianhua Ge; Ramazan Asmatulu; Bo Zhu; Qiu Zhang; Shang-You Yang
Journal:  Bioengineering (Basel)       Date:  2022-06-26
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.